These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15764852)

  • 1. Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.
    Turriziani O; Butera O; Gianotti N; Parisi SG; Mazzi R; Girardi E; Iaiani G; Antonelli L; Lazzarin A; Antonelli G
    AIDS; 2005 Mar; 19(5):473-9. PubMed ID: 15764852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine kinase and deoxycytidine kinase in HIV-infected children.
    Falasca F; Maida P; Boni A; Bernardi S; Cursi L; Rizzo B; Antonelli G; Gattinara GC; Turriziani O
    New Microbiol; 2009 Oct; 32(4):411-3. PubMed ID: 20128449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolites.
    Paintsil E; Dutschman GE; Hu R; Grill SP; Wang CJ; Lam W; Li FY; Ghebremichael M; Northrup V; Cheng YC
    Antimicrob Agents Chemother; 2011 Feb; 55(2):895-903. PubMed ID: 21078952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in thymidylate kinase activity in peripheral blood mononuclear cells from HIV-infected individuals.
    Jacobsson B; Britton S; Törnevik Y; Eriksson S
    Biochem Pharmacol; 1998 Aug; 56(3):389-95. PubMed ID: 9744577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients.
    Turriziani O; Gianotti N; Bambacioni F; Manconi PE; Lazzarin A; Antonelli G
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):701-3. PubMed ID: 15307913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cellular thymidine kinase 1 in PBMC of HIV-1-infected patients: novel therapy marker.
    Gröschel B; Miller V; Doerr HW; Cinatl J
    Infection; 2000; 28(4):209-13. PubMed ID: 10961525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
    Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
    Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism.
    Jacobsson B; Britton S; He Q; Karlsson A; Eriksson S
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):805-11. PubMed ID: 7546907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of thymidine kinase activity in cells treated with an antiviral agent.
    Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F
    J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of deoxycytidine kinase by various nucleoside analogues.
    Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
    Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
    Arnér ES; Spasokoukotskaja T; Eriksson S
    Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
    Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
    Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients.
    Latronico T; Liuzzi GM; Riccio P; Lichtner M; Mengoni F; D'Agostino C; Vullo V; Mastroianni CM
    AIDS; 2007 Mar; 21(6):677-84. PubMed ID: 17413688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-acyl-2-thioethyl (SATE) pronucleotides are potent inhibitors of HIV-1 replication in T-lymphoid cells cross-resistant to deoxycytidine and thymidine analogs.
    Gröschel B; Cinatl J; Périgaud C; Gosselin G; Imbach JL; Doerr HW; Cinatl J
    Antiviral Res; 2002 Feb; 53(2):143-52. PubMed ID: 11750940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and activity of thymidine kinase 1 and deoxycytidine kinase are modulated by hydrogen peroxide and nucleoside analogs.
    Sun R; Eriksson S; Wang L
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1347-1358. PubMed ID: 32189555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.
    Nielsen SE; Munch-Petersen B; Mejer J
    Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and cellular factors for resistance against antiretroviral agents.
    Gröschel B; Cinatl J; Cinatl J
    Intervirology; 1997; 40(5-6):400-7. PubMed ID: 9675644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy abrogates association between arginase activity and HIV disease severity.
    Cloke TE; Abebe T; Hailu A; Munder M; Taylor GP; Müller I; Kropf P
    Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):746-8. PubMed ID: 20843532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.